From October 1, 2022 to December 29, 2022, the company has repurchased 120,000 shares, representing 2% for KRW 3,418.04 million. With this, the company has completed the repurchase of 120,000 shares, representing 2% for KRW 3,418.04 million under the buyback announced on September 28, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28,550 KRW | +0.18% | +0.53% | +2.88% |
2023 | Daihan Pharmaceutical Co.,Ltd.(KOSDAQ:A023910) dropped from S&P Global BMI Index | CI |
2023 | Daihan Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.88% | 124M | |
+20.32% | 43.95B | |
+22.22% | 22.49B | |
+11.68% | 14.71B | |
+11.31% | 13.77B | |
+42.32% | 12.3B | |
-8.70% | 7.03B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.33% | 5.48B |
- Stock Market
- Equities
- A023910 Stock
- News Daihan Pharmaceutical Co.,Ltd.
- Tranche Update on Daihan Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 28, 2022.